40 /100
MEDIUM RISK
Score updated May 30, 2026

ZBIO — Zenas BioPharma, Inc. Dilution Risk Tracker

Track ZBIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ZBIO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ZBIO.
🔔 Track ZBIO — Get forecast alerts →

💹 Market Data

Market Cap$1.16B
Shares Outstanding63.13M
Float39.68M
Cash$717.20M
Debt$266.83M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 20.3% shares (2025Q4 vs prior)
126 institutional holders · 42.10M shares
#1 FMR LLC 7.70M shares
#2 SR One Capital Management, LP 5.04M shares
#3 ENAVATE SCIENCES GP, LLC 3.92M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest10.69M
Days to Cover21.3
% of Float26.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track ZBIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ZBIO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for ZBIO
📊 ZBIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ZBIO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.